1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SLC15A4 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA RRNAD1 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA ANGEL1 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA CDKN1B CTRPv2 pan-cancer AAC 0.086 0.01
mRNA NAPB CTRPv2 pan-cancer AAC 0.083 0.01
mRNA MS4A2 CTRPv2 pan-cancer AAC -0.081 0.01
mRNA SPCS1 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA USP48 CTRPv2 pan-cancer AAC -0.093 0.01
mRNA GPATCH8 CTRPv2 pan-cancer AAC 0.087 0.01
mRNA PRELID2 CTRPv2 pan-cancer AAC -0.084 0.01
Download CSV